The Company Presentation Stage at Life Sciences Future provides an unparalleled opportunity for small and emerging companies to present their technology, data, business plan, and opportunities for investment and partnership to a large and diverse life sciences audience. 


Selected companies will have ten minutes to present to an audience that includes global pharma and device companies, investor groups, research institutions, fellow startups, key strategic partners, and others.


Companies are selected by a review committee considering the following criteria: stage of development; intellectual property protection; expected time of next capital raise; whether the technology is licensable; and conference appeal to the bioscience industry or other potential partners. Presentation must be hosted by the company CEO or a designated executive. Presentation will focus on corporate missions and types of opportunities sought.

*Only core member companies (biotech, pharmaceutical, medical device and diagnostic) currently performing research and development are eligible.


Day One Presenters:

1:15 – 1:25PM          Isoma Diagnostics

1:40 – 1:50PM         Socium Therapeutics

2:25 – 2:35PM         Aro Biotherapeutics

2:50 – 3:00PM         Ariel Precision Medicine

3:15 – 3:25PM         AmorSui

3:45 – 3:55PM         ViCardia Therapeutics Inc.

4:10 – 4:20PM         Carmell Therapeutics

Day Two Presenters:

10:30 – 10:40AM               Prolifagen

10:40 – 10:50AM                Face2Face Health

11:25 – 11:35AM                Atrin Pharmaceuticals

11:55AM – 12:05 PM          BioMagnetic Solutions

12:20 – 12:30PM                Thermaquil

12:30 – 12:40PM                PolyAurum

2:25 – 2:35PM                    WindMIL Therapeutics

3:10 – 3:20PM                    PepVax, Inc.